129 related articles for article (PubMed ID: 3225641)
1. Intrathecal ACNU--a new therapeutic approach against malignant leptomeningeal tumors.
Arita N; Ushio Y; Hayakawa T; Nagatani M; Huang TY; Izumoto S; Mogami H
J Neurooncol; 1988 Nov; 6(3):221-6. PubMed ID: 3225641
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of intrathecal 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride in rats.
Huang TY; Arita N; Ushio Y; Hayakawa T; Yamada K
J Neurooncol; 1994; 19(3):245-50. PubMed ID: 7807175
[TBL] [Abstract][Full Text] [Related]
3. [Intrathecal ACNU against malignant leptomeningeal tumors--toxicity and therapeutic effect in experimental animals].
Nagatani M; Arita N; Ushio Y; Hayakawa T; Tzuu-Yuan H; Yoshimine T; Mori S; Mogami H
No To Shinkei; 1986 Nov; 38(11):1071-5. PubMed ID: 3468960
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal ACNU against experimental leptomeningeal tumors.
Huang TY; Howng SL
Kaohsiung J Med Sci; 1997 Oct; 13(10):626-30. PubMed ID: 9385779
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal chemotherapy with ACNU in a meningeal gliomatosis rat model.
Yoshida TK; Shimizu K; Koulousakis A; Sturm V
J Neurosurg; 1992 Nov; 77(5):778-82. PubMed ID: 1403122
[TBL] [Abstract][Full Text] [Related]
6. [Distribution of ACNU in the rat brain after intracisternal injection--macroscopical autoradiographic study].
Huang TY; Arita N; Ushio Y; Hayakawa T; Nagatani M; Mogami H
No To Shinkei; 1987 Mar; 39(3):263-6. PubMed ID: 3472532
[TBL] [Abstract][Full Text] [Related]
7. ACNU, MTX and 5-FU penetration of rat brain tissue and tumors.
Huang TY; Arita N; Hayakawa T; Ushio Y
J Neurooncol; 1999; 45(1):9-17. PubMed ID: 10728905
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal chemotherapy with ACNU for meningeal gliomatosis.
Yoshida TK; Beuls E; Shimizu K; Koulousakis A; Sturm V
Br J Cancer; 1992 Dec; 66(6):999-1004. PubMed ID: 1457369
[TBL] [Abstract][Full Text] [Related]
9. [Intrathecal ACNU for the treatment of a meningeal gliomatosis model].
Yoshida T; Shimizu K; Mogami H; Egawa T; Sakamoto Y
Gan To Kagaku Ryoho; 1987 Jan; 14(1):84-90. PubMed ID: 3467657
[TBL] [Abstract][Full Text] [Related]
10. Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosou rea hydrochloride.
Kochi M; Kuratsu J; Mihara Y; Takaki S; Seto H; Uemura S; Ushio Y
Neurosurgery; 1993 Nov; 33(5):817-23. PubMed ID: 8264878
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride and bleomycin in meningeal carcinomatosis in rats.
Shimizu K; Ushio Y; Hayakawa T; Mogami H
Cancer Res; 1980 Apr; 40(4):1341-3. PubMed ID: 6153573
[TBL] [Abstract][Full Text] [Related]
12. Alteration of blood-CSF barrier by tumor invasion into the meninges.
Ushio Y; Shimizu K; Aragaki Y; Arita N; Hayakawa T; Mogami H
J Neurosurg; 1981 Sep; 55(3):445-9. PubMed ID: 6943305
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal ACNU treatment of B16 melanoma leptomeningeal metastasis in a new athymic rat model.
Schabet M; Ohneseit P; Buchholz R; Santo-Höltje L; Schmidberger H
J Neurooncol; 1992 Oct; 14(2):169-75. PubMed ID: 1432039
[TBL] [Abstract][Full Text] [Related]
14. Neurotoxicity and pharmacokinetics of intrathecal perfusion of ACNU in dogs.
Kochi M; Kuratsu J; Mihara Y; Takaki S; Inoue N; Sueyoshi N; Uemura S; Ushio Y
Cancer Res; 1990 May; 50(10):3119-23. PubMed ID: 2334907
[TBL] [Abstract][Full Text] [Related]
15. [Effect of ACNU against experimental brain tumor--immunohistochemical study using anti-BrdU monoclonal antibody].
Izumoto S; Arita N; Ushio Y; Hayakawa T; Yoshimine T; Tzuu-Yuan H; Nagatani M; Oku Y; Mogami H
No To Shinkei; 1988 Nov; 40(11):1095-9. PubMed ID: 3219244
[TBL] [Abstract][Full Text] [Related]
16. Phase I/II study of intraventricular and intrathecal ACNU for leptomeningeal neoplasia.
Levin VA; Chamberlain M; Silver P; Rodriguez L; Prados M
Cancer Chemother Pharmacol; 1989; 23(5):301-7. PubMed ID: 2706735
[TBL] [Abstract][Full Text] [Related]
17. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
Kooistra KL; Rodriguez M; Powis G
Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models.
Sugiyama S; Yamashita Y; Kikuchi T; Saito R; Kumabe T; Tominaga T
J Neurooncol; 2007 Mar; 82(1):41-7. PubMed ID: 17031554
[TBL] [Abstract][Full Text] [Related]
19. Timing of hypertonic glucose and thermochemotherapy with 1-(4-amino-2-methylpyrimidine-5-yl) methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU) in the BT4An rat glioma: relation to intratumoral pH reduction and circulatory changes after glucose supply.
Schem BC; Roszinski S; Krossnes BK; Mella O
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):409-16. PubMed ID: 7673028
[TBL] [Abstract][Full Text] [Related]
20. Thermal enhancement of ACNU and potentiation of thermochemotherapy with ACNU by hypertonic glucose in the BT4An rat glioma.
Schem BC; Dahl O
J Neurooncol; 1991 Jun; 10(3):247-52. PubMed ID: 1895166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
